Brainstorm Cell Therapeutics Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
Electronic Technology » Computer Peripherals
WDCWestern Digital Corporation
STXSeagate Technology PLC
NTAPNetApp, Inc.
PSTGPure Storage, Inc. Class A
ZBRAZebra Technologies Corporation Class A
SYNASynaptics Incorporated
EFIIElectronics For Imaging, Inc.
LOGILogitech International S.A.
IMMRImmersion Corporation
ITUSITUS Corporation
AVIDAvid Technology, Inc.
QTMQuantum Corporation
QBAKQualstar Corporation
ALOTAstro-Med, Inc.
BCLIBrainstorm Cell Therapeutics Inc.

Company Profile

Brainstorm Cell Therapeutics, Inc. operates as a biotechnology company, which develops innovative adult stem cell therapeutic products. It focuses on utilizing the patients own bone marrow stem cells to generate neuron-like cells that may provide an effective treatment initially for amyotrophic lateral sclerosis, Parkinson's disease, multiple sclerosis and spinal cord injury. The company was founded on September 22, 2000 and is headquartered in Hackensack, NJ.